Benjamin W Van Tassell Selected Research

Doxorubicin (Adriamycin)

7/2015	Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse.
1/2013	Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benjamin W Van Tassell Research Topics

Disease

36	Heart Failure 01/2023 - 05/2007
27	Myocardial Infarction 01/2022 - 09/2007
15	Inflammation (Inflammations) 01/2023 - 12/2011
14	Infarction (Infarctions) 01/2019 - 06/2009
12	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 09/2007
11	ST Elevation Myocardial Infarction 01/2023 - 03/2014
9	COVID-19 01/2022 - 01/2020
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 06/2009
7	Left Ventricular Dysfunction 01/2019 - 01/2012
7	Ischemia 07/2016 - 06/2009
5	Fibrosis (Cirrhosis) 01/2022 - 10/2012
4	Neoplasms (Cancer) 01/2022 - 06/2009
4	Thrombosis (Thrombus) 01/2022 - 08/2012
4	Pericarditis 01/2022 - 01/2018
4	Systolic Heart Failure 10/2020 - 01/2012
4	Hypertrophy 09/2015 - 04/2010
4	Heart Diseases (Heart Disease) 02/2015 - 10/2013
3	Obesity 10/2022 - 09/2007
3	Dyslipidemias (Dyslipidemia) 12/2021 - 05/2021
3	Body Weight (Weight, Body) 01/2021 - 01/2018
3	Type 2 Diabetes Mellitus (MODY) 11/2020 - 06/2014
3	Reperfusion Injury 01/2019 - 10/2012
2	Injection Site Reaction 11/2022 - 01/2020
2	Infections 11/2022 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2020
2	Critical Illness (Critically Ill) 01/2021 - 01/2021
2	Myocarditis (Carditis) 01/2020 - 02/2014
2	Atherosclerosis 01/2020 - 08/2012
2	Cardiomyopathies (Cardiomyopathy) 01/2020 - 03/2015
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2013
2	Hypoxia (Hypoxemia) 01/2013 - 10/2011
2	Hypertension (High Blood Pressure) 09/2007 - 03/2007
1	Hemorrhage 03/2024
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 03/2024
1	Bradycardia 05/2023
1	Atrial Fibrillation 05/2023
1	Hypotension (Low Blood Pressure) 05/2023
1	Dyspnea (Shortness of Breath) 05/2023
1	Sarcoidosis (Schaumann Disease) 01/2023
1	Pain (Aches) 01/2023

Drug/Important Bio-Agent (IBA)

30	Interleukin-1 (Interleukin 1)IBA 01/2023 - 02/2010
17	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023 - 05/2010
11	InflammasomesIBA 01/2022 - 12/2011
9	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022 - 01/2011
6	C-Reactive ProteinIBA 10/2022 - 11/2014
6	CytokinesIBA 08/2020 - 02/2010
5	LipidsIBA 11/2022 - 09/2007
5	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 05/2007
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 09/2007
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2011
4	Colchicine FDA LinkGeneric 10/2022 - 01/2018
4	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2016
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2024 - 01/2021
3	Monoclonal AntibodiesIBA 12/2021 - 07/2014
3	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 04/2014
3	Small Interfering RNA (siRNA)IBA 01/2013 - 04/2010
2	Carvedilol (Coreg)FDA LinkGeneric 05/2023 - 08/2008
2	Oxygen (Dioxygen)IBA 10/2022 - 01/2019
2	AntibodiesIBA 12/2021 - 06/2014
2	alirocumabIBA 12/2021 - 01/2019
2	oxidized low density lipoproteinIBA 12/2021 - 01/2019
2	dalcetrapibIBA 10/2021 - 05/2021
2	Niacin (Nicotinic Acid)FDA LinkGeneric 10/2021 - 05/2021
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2021 - 05/2021
2	HDL CholesterolIBA 10/2021 - 05/2021
2	Fibric Acids (Fibrates)IBA 10/2021 - 05/2021
2	Triglycerides (Triacylglycerol)IBA 10/2021 - 05/2021
2	Carbon DioxideIBA 11/2020 - 01/2019
2	dapansutrileIBA 10/2020 - 01/2019
2	canakinumab FDA Link 01/2020 - 08/2012
2	rilonacept FDA Link 01/2020 - 02/2010
2	Angiotensin IIIBA 09/2015 - 10/2011
2	Troponin IIBA 07/2015 - 04/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2015 - 01/2013
2	InterleukinsIBA 03/2015 - 11/2014
2	LipopolysaccharidesIBA 02/2015 - 06/2014
2	Interleukin-18 (Interleukin 18)IBA 06/2014 - 04/2014
2	Adenosine Triphosphate (ATP)IBA 06/2014 - 12/2011
2	5- quinoxalin- 6- ylmethylenethiazolidine- 2,4- dioneIBA 12/2010 - 07/2010
1	Proton Pump InhibitorsIBA 03/2024
1	Histamine (Histamine Dihydrochloride)FDA Link 03/2024
1	Metoprolol (Toprol-XL)FDA LinkGeneric 05/2023
1	polycarbonateIBA 01/2023
1	PlasticsIBA 01/2023
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2022
1	Peptides (Polypeptides)IBA 11/2022
1	SerpinsIBA 11/2022
1	P-SelectinIBA 10/2022
1	TroponinIBA 10/2022

Therapy/Procedure

11	Therapeutics 03/2024 - 09/2007
4	Radiotherapy 01/2022 - 01/2020
3	Ligation 01/2019 - 06/2009
2	Percutaneous Coronary Intervention 11/2022 - 10/2022
2	Critical Care (Surgical Intensive Care) 01/2022 - 08/2020
2	Extracorporeal Membrane Oxygenation 01/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 12/2021 - 12/2008
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2023
1	Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump) 05/2023
1	Time-to-Treatment 01/2023